| Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes M Robertson-Tessi, RJ Gillies, RA Gatenby, ARA Anderson Cancer research 75 (8), 1567-1579, 2015 | 307 | 2015 |
| A mathematical model of tumor–immune interactions M Robertson-Tessi, A El-Kareh, A Goriely Journal of theoretical biology 294, 56-73, 2012 | 191 | 2012 |
| Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer A El-Kenawi, C Gatenbee, M Robertson-Tessi, R Bravo, J Dhillon, ... British journal of cancer 121 (7), 556-566, 2019 | 138 | 2019 |
| Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution A Ibrahim-Hashim, M Robertson-Tessi, PM Enriquez-Navas, M Damaghi, ... Cancer research 77 (9), 2242-2254, 2017 | 137 | 2017 |
| Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions JT Poleszczuk, KA Luddy, S Prokopiou, M Robertson-Tessi, EG Moros, ... Cancer research 76 (5), 1009-1018, 2016 | 125 | 2016 |
| Turnover modulates the need for a cost of resistance in adaptive therapy MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ... Cancer research 81 (4), 1135-1147, 2021 | 117 | 2021 |
| The harsh microenvironment in early breast cancer selects for a Warburg phenotype M Damaghi, J West, M Robertson-Tessi, L Xu, MC Ferrall-Fairbanks, ... Proceedings of the National Academy of Sciences 118 (3), e2011342118, 2021 | 113 | 2021 |
| Evolutionary dynamics of neoantigens in growing tumors E Lakatos, MJ Williams, RO Schenck, WCH Cross, J Househam, L Zapata, ... Nature genetics 52 (10), 1057-1066, 2020 | 113 | 2020 |
| Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualization RR Bravo, E Baratchart, J West, RO Schenck, AK Miller, J Gallaher, ... PLoS computational biology 16 (3), e1007635, 2020 | 95 | 2020 |
| Elastic growth models A Goriely, M Robertson-Tessi, M Tabor, R Vandiver Mathematical modelling of biosystems, 1-44, 2008 | 84* | 2008 |
| Normal tissue architecture determines the evolutionary course of cancer J West, RO Schenck, C Gatenbee, M Robertson-Tessi, ARA Anderson Nature communications 12 (1), 2060, 2021 | 76 | 2021 |
| Spatial structure impacts adaptive therapy by shaping intra-tumoral competition MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ... Communications medicine 2 (1), 46, 2022 | 64 | 2022 |
| The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition KA Luddy, M Robertson-Tessi, NK Tafreshi, H Soliman, DL Morse Frontiers in immunology 5, 429, 2014 | 54 | 2014 |
| A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ... Elife 12, e84263, 2023 | 49 | 2023 |
| Stochasticity in the genotype-phenotype map: implications for the robustness and persistence of bet-hedging D Nichol, M Robertson-Tessi, P Jeavons, ARA Anderson Genetics 204 (4), 1523-1539, 2016 | 46 | 2016 |
| Virtual alignment of pathology image series for multi-gigapixel whole slide images CD Gatenbee, AM Baker, S Prabhakaran, O Swinyard, RJC Slebos, ... Nature communications 14 (1), 4502, 2023 | 45* | 2023 |
| Agent-based methods facilitate integrative science in cancer J West, M Robertson-Tessi, ARA Anderson Trends in cell biology 33 (4), 300-311, 2023 | 42 | 2023 |
| Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues C Gabbutt, RO Schenck, DJ Weisenberger, C Kimberley, A Berner, ... Nature biotechnology 40 (5), 720-730, 2022 | 42 | 2022 |
| The goldilocks window of personalized chemotherapy: getting the immune response just right DS Park, M Robertson-Tessi, KA Luddy, PK Maini, MB Bonsall, ... Cancer research 79 (20), 5302-5315, 2019 | 42 | 2019 |
| Immunosuppressive niche engineering at the onset of human colorectal cancer CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ... Nature Communications 13 (1), 1798, 2022 | 36 | 2022 |
Alexander R. A. AndersonChair of Integrated Mathematical Oncology, Moffitt Cancer CenterVerified email at moffitt.org
